Clinical Trials Directory

Trials / Completed

CompletedNCT04771923

Tranexamic Acid Versus Adrenaline for Controlling Iatrogenic Endobronchial Bleeding

Tranexamic Acid Versus Adrenaline for Controlling Iatrogenic Endobronchial Bleeding: a Double Blind, Randomized Controlled Trial

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
130 (actual)
Sponsor
Clinical Hospital Centre Zagreb · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Endobronchial bleeding is a relatively common complication of diagnostic bronchoscopy. Both tranexamic acid and adrenaline are used topically for the control of endobronchial bleeding. The aim of this study is to compare the efficacy of tranexamic acid with adrenaline in controlling iatrogenic endobronchial bleeding after diagnostic bronchoscopy.

Conditions

Interventions

TypeNameDescription
DRUGTranexamic acidTopical instillation of tranexamic acid up to 3x. If bleeding is not controlled patients crossover to adrenaline.
DRUGAdrenalineTopical instillation of adrenaline up to 3x. If bleeding is not controlled patients crossover to tranexamic acid.

Timeline

Start date
2021-02-22
Primary completion
2022-02-04
Completion
2022-02-04
First posted
2021-02-25
Last updated
2022-02-24

Locations

1 site across 1 country: Croatia

Source: ClinicalTrials.gov record NCT04771923. Inclusion in this directory is not an endorsement.

Tranexamic Acid Versus Adrenaline for Controlling Iatrogenic Endobronchial Bleeding (NCT04771923) · Clinical Trials Directory